Rocuronium Bromide Injection
Product Images NDC 25021-687

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 25021-687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Roc08 0000 01)

Structural Formula (Roc08 0000 01)
Chemical structure of Rocuronium Bromide shown as a molecular diagram with labeled functional groups and ionic species.*
FDA Label Image

Figure 1 (Roc08 0000 02)

Figure 1 (Roc08 0000 02)
A box plot chart showing time in minutes on the y-axis and dosage in mg/kg on the x-axis across three age groups: 18-64 years, 65 years and older, and 1-12 years. The chart displays distribution of times for different dosage levels within each age group.*
FDA Label Image

Figure 2 (Roc08 0000 03)

Figure 2 (Roc08 0000 03)
A box-and-whisker plot comparing duration in minutes across different age groups and doses in mg/kg for Rocuronium Bromide injection. The x-axis shows age groups 18-64, >=65 years, 3 months to 1 year, and 1-12 years each with varying doses, while the y-axis represents duration in minutes up to 160 minutes.*
FDA Label Image

Figure 3 (Roc08 0000 04)

Figure 3 (Roc08 0000 04)
A line graph showing duration in minutes on the vertical axis versus dose number on the horizontal axis. Two data series represent doses of 0.1 mg/kg (N=29) and 0.15 mg/kg (N=13), indicating how duration changes over multiple doses.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Roc08 0000 05)

Package Label – Principal Display Panel – Vial Label (Roc08 0000 05)
Label for Rocuronium Bromide Injection, 10 mg/mL strength, in a 5 mL multi-dose vial. It contains 50 mg per 5 mL and is indicated as a paralyzing agent for intravenous use only. The label includes storage instructions, warning statements, and manufacturer information for Sagent Pharmaceuticals, made in India.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Roc08 0000 06)

Package Label – Principal Display Panel – Vial Label (Roc08 0000 06)
Rocuronium Bromide Injection 100 mg per 10 mL (10 mg per mL) multi-dose vial label by Sagent Pharmaceuticals. The label includes warnings about paralyzing effects, specifies intravenous use only, and provides storage instructions. The label shows the NDC 25021-687-10 and states the product is preservative-free and nonpyrogenic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.